554 related articles for article (PubMed ID: 15748903)
81. A mouse mammary tumor virus-like long terminal repeat superantigen in human breast cancer.
Wang Y; Jiang JD; Xu D; Li Y; Qu C; Holland JF; Pogo BG
Cancer Res; 2004 Jun; 64(12):4105-11. PubMed ID: 15205319
[TBL] [Abstract][Full Text] [Related]
82. Specific deactivation of the mouse mammary tumor virus long terminal repeat promoter upon continuous hormone treatment.
Boronat S; Richard-Foy H; Piña B
J Biol Chem; 1997 Aug; 272(35):21803-10. PubMed ID: 9268310
[TBL] [Abstract][Full Text] [Related]
83. Intrinsic promoter nucleosome stability/dynamics variations support a novel targeting mechanism.
Kelbauskas L; Yodh J; Woodbury N; Lohr D
Biochemistry; 2009 May; 48(20):4217-9. PubMed ID: 19374398
[TBL] [Abstract][Full Text] [Related]
84. Nuclear factor I acts as a transcription factor on the MMTV promoter but competes with steroid hormone receptors for DNA binding.
Brüggemeier U; Rogge L; Winnacker EL; Beato M
EMBO J; 1990 Jul; 9(7):2233-9. PubMed ID: 2162764
[TBL] [Abstract][Full Text] [Related]
85. Binding of NF1 to the MMTV promoter in nucleosomes: influence of rotational phasing, translational positioning and histone H1.
Eisfeld K; Candau R; Truss M; Beato M
Nucleic Acids Res; 1997 Sep; 25(18):3733-42. PubMed ID: 9278498
[TBL] [Abstract][Full Text] [Related]
86. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
87. Effects of antiandrogens on chromatin remodeling and transcription of the integrated mouse mammary tumor virus promoter.
List HJ; Smith CL; Martinez E; Harris VK; Danielsen M; Riegel AT
Exp Cell Res; 2000 Oct; 260(1):160-5. PubMed ID: 11010820
[TBL] [Abstract][Full Text] [Related]
88. Structure and dynamic properties of a glucocorticoid receptor-induced chromatin transition.
Fletcher TM; Ryu BW; Baumann CT; Warren BS; Fragoso G; John S; Hager GL
Mol Cell Biol; 2000 Sep; 20(17):6466-75. PubMed ID: 10938123
[TBL] [Abstract][Full Text] [Related]
89. Transforming growth factor beta enhances the glucocorticoid response of the mouse mammary tumor virus promoter through Smad and GA-binding proteins.
Aurrekoetxea-Hernández K; Buetti E
J Virol; 2004 Mar; 78(5):2201-11. PubMed ID: 14963116
[TBL] [Abstract][Full Text] [Related]
90. Up-regulation of the HSP72 by Foxa1 in MCF-7 human breast cancer cell line.
Song L; Xu Z; Zhang C; Qiao X; Huang C
Biochem Biophys Res Commun; 2009 Aug; 386(1):30-4. PubMed ID: 19486887
[TBL] [Abstract][Full Text] [Related]
91. CDP is a repressor of mouse mammary tumor virus expression in the mammary gland.
Zhu Q; Gregg K; Lozano M; Liu J; Dudley JP
J Virol; 2000 Jul; 74(14):6348-57. PubMed ID: 10864645
[TBL] [Abstract][Full Text] [Related]
92. Histone H1 phosphorylation by Cdk2 selectively modulates mouse mammary tumor virus transcription through chromatin remodeling.
Bhattacharjee RN; Banks GC; Trotter KW; Lee HL; Archer TK
Mol Cell Biol; 2001 Aug; 21(16):5417-25. PubMed ID: 11463824
[TBL] [Abstract][Full Text] [Related]
93. The histone binding protein nucleoplasmin does not facilitate binding of transcription factor IIIA to nucleosomal Xenopus laevis 5S rRNA genes.
Howe L; Itoh T; Katagiri C; Ausio J
Biochemistry; 1998 Feb; 37(5):1174-7. PubMed ID: 9477940
[TBL] [Abstract][Full Text] [Related]
94. The mouse mammary tumor virus promoter adopts distinct chromatin structures in human breast cancer cells with and without glucocorticoid receptor.
Kinyamu HK; Fryer CJ; Horwitz KB; Archer TK
J Biol Chem; 2000 Jun; 275(26):20061-8. PubMed ID: 10751396
[TBL] [Abstract][Full Text] [Related]
95. Interplay of steroid hormone receptors and transcription factors on the mouse mammary tumor virus promoter.
Truss M; Chalepakis G; Beato M
J Steroid Biochem Mol Biol; 1992 Oct; 43(5):365-78. PubMed ID: 1327070
[TBL] [Abstract][Full Text] [Related]
96. DNA instructed displacement of histones H2A and H2B at an inducible promoter.
Vicent GP; Nacht AS; Smith CL; Peterson CL; Dimitrov S; Beato M
Mol Cell; 2004 Nov; 16(3):439-52. PubMed ID: 15525516
[TBL] [Abstract][Full Text] [Related]
97. Promoter complex in the central part of the mouse mammary tumor virus long terminal repeat.
Rouault F; Nejad Asl SB; Rungaldier S; Fuchs E; Salmons B; Günzburg WH
J Virol; 2007 Nov; 81(22):12572-81. PubMed ID: 17686873
[TBL] [Abstract][Full Text] [Related]
98. The matrix attachment region-binding protein SATB1 participates in negative regulation of tissue-specific gene expression.
Liu J; Bramblett D; Zhu Q; Lozano M; Kobayashi R; Ross SR; Dudley JP
Mol Cell Biol; 1997 Sep; 17(9):5275-87. PubMed ID: 9271405
[TBL] [Abstract][Full Text] [Related]
99. Stably integrated mouse mammary tumor virus long terminal repeat DNA requires the octamer motifs for basal promoter activity.
Buetti E
Mol Cell Biol; 1994 Feb; 14(2):1191-203. PubMed ID: 8289800
[TBL] [Abstract][Full Text] [Related]
100. Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation.
Gao N; Ishii K; Mirosevich J; Kuwajima S; Oppenheimer SR; Roberts RL; Jiang M; Yu X; Shappell SB; Caprioli RM; Stoffel M; Hayward SW; Matusik RJ
Development; 2005 Aug; 132(15):3431-43. PubMed ID: 15987773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
